Inside the OEM: Boston Scientific to Focus on Cardiology Innovation

Boston Scientific entered 2025 with significant momentum. Fresh off a standout first quarter, the company’s leadership has outlined a compelling vision for sustainable long-term growth rooted in high-performing cardiology franchises, operational precision, and disruptive technologies in electrophysiology (EP). Leaders spoke at a recent Bank of America Healthcare Conference. The discussion marked outgoing CFO Dan Brennan’s final investor presentation and underscored Boston Scientific’s transformation into one of medtech’s most durable growth stories.